FranΓ§aisπ See the interactive version (live chart) β
For Xylem Inc., we replayed every analyst price target of the past 12 months and measured the real outcome: 36% were profitable, average return +8% (126 calls). At 3 months: +3% average return (40% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Stifel | 20 | 25% | +9% |
| RBC Capital | 20 | 40% | +15% |
| Credit Suisse | 13 | 31% | -12% |
| Oppenheimer | 8 | 38% | +8% |
| Baird | 7 | 29% | +8% |
Is Xylem Inc. overvalued, and is it a good time to buy Xylem Inc. right now? If you're wondering, here's a recap to make up your own mind: Xylem Inc.'s valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | Xylem Inc. | Sector median (Industrials) |
|---|---|---|
| P/E | 26.8 | 29.2 |
| Forward P/E | 18.0 | 19.5 |
| Net margin | 11% | 11% |
π Xylem Inc. is valued in line with its sector (26.8 vs 29.2).
π P/E, PEG, marginβ¦: see the glossary
π΅ Dividend : Xylem Inc. pays about $1.66/share/yr β 1.42% yield. what is this?
The analyst consensus on Xylem Inc. (XYL) is "Buy" (29 bullish, 0 bearish calls over 12 months). This is not advice: historically, 36% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $160 (+42% vs $113), ranging from $130 to $168 (10 analysts).
Over 1 year, 36% of analyst targets on Xylem Inc. were profitable, for an average return of +8% (across 126 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $160 within 12 months, i.e. +42% vs the current price. The most bullish targets $168, the most cautious $130.
Note: analyst targets are 12-month (median $160, +42%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (36%), and the stock's past trajectory.
Its P/E is 26.8, forward P/E 18.0. A forward P/E lower than the current P/E means earnings are expected to grow.
π See the full interactive analysis of Xylem Inc. β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.